Indication
Scabies
13 clinical trials
10 products
1 drug
Product
SpinosadClinical trial
A Single Treatment Pharmacokinetic and Safety Study of Natroba (Spinosad) Topical Suspension 0.9% w/w in Subjects 1 Month to 3 Years 11 Months of Age With an Active Scabies InfestationStatus: Recruiting, Estimated PCD: 2025-11-30
Clinical trial
Phase III Multicenter, Prospective, Randomized, Double-blind Study Comparing the Efficacy and Safety of Therapy for Scabies With Two Differently Concentrated Permethrin Creams.Status: Not yet recruiting, Estimated PCD: 2027-07-01
Product
PermethrinProduct
10% Permethrin CremeClinical trial
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison Study of the Safety and Efficacy of Permethrin Foam, 5% Versus Permethrin Foam, 4% Versus Vehicle in Subjects With Sarcoptes ScabieiStatus: Completed, Estimated PCD: 2014-12-01
Product
Permethrin FoamProduct
Vehicle FoamClinical trial
A Phase II, Randomized, Double-blind, Parallel Group Dose Finding Study of Single Oral Doses of Moxidectin in Adults With ScabiesStatus: Completed, Estimated PCD: 2022-02-28
Product
MoxidectinClinical trial
A Randomised, Double-blind, Placebo-controlled Trial to Assess the Safety, Pharmacokinetics, and Efficacy of Escalating Doses of Oral Ivermectin in Scabies Infected Children Weighing 5 to Less Than 15 KilogramsStatus: Recruiting, Estimated PCD: 2024-12-01
Product
IvermectinClinical trial
A Randomized Controlled Double-blind Trial Assessing the Efficacy of a 400µg/kg Ivermectin /5% Permethrin / Emollient Cream Regimen in Patients With Crusted Scabies as Compared to a 200µg/kg Ivermectin /5% Permethrin /Emollient Cream RegimenStatus: Completed, Estimated PCD: 2022-01-12
Clinical trial
A Phase 2, Placebo-controlled, Double-blind, Randomized, Dose Ranging, Efficacy and Safety Study of Orally Administered Moxidectin in Adults With Scabies.Status: Recruiting, Estimated PCD: 2024-09-30
Drug
VarlilumabClinical trial
Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of ScabiesStatus: Completed, Estimated PCD: 2022-09-30
Product
SulphurClinical trial
Comparison of Effectiveness Between Three Dosages of Oral Ivermectin, Two Dosages of Oral Ivermectin, and Two Applications of Topical Permethrin In Scabies PatientsStatus: Completed, Estimated PCD: 2023-02-01
Clinical trial
Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)Status: Not yet recruiting, Estimated PCD: 2026-06-01
Clinical trial
Comparing Sulfur to Different Regimes of Permethrin for the Treatment of ScabiesStatus: Completed, Estimated PCD: 2022-09-15
Product
SulfurClinical trial
A Randomized Trial to Assess the Safety, Pharmacokinetics, Acceptability, and Efficacy of Pediatric Oral Ivermectin in Scabies Infected Children Weighing 5 to Less Than 15 KilogramsStatus: Not yet recruiting, Estimated PCD: 2025-09-30
Product
CHILD-IVITABClinical trial
Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children: a Cluster Multicenter Randomized TrialStatus: Completed, Estimated PCD: 2021-12-16